Advertisement PerkinElmer's Q2 revenue up - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

PerkinElmer’s Q2 revenue up

PerkinElmer has reported total revenue of $528.6 million for the second quarter of 2008, an increase of 21%, compared to the second quarter of 2007.

Revenue growth was 22% in life and analytical sciences and 19% in optoelectronics compared to the same period a year ago.

On a non-GAAP basis, the company posted an adjusted operating profit of $63.8 million for the second quarter of 2008, up 26%, as compared to $50.8 million reported in the second quarter of 2007.

Robert Friel, president and CEO of PerkinElmer, said: During the second quarter, we experienced excellent growth across the entire portfolio, enabling us to exceed our profit and cash flow expectations. The strength of our businesses and geographic diversity position us for a strong 2008.